On another call https://www.shopgt.com/index.php/raymedyde-49b8.pdf#interior kazakhstan.medochemie.com  However, it looks like much of this good news is now in the price. The shares trade on a 2013 forecast multiple of 27.3 times, falling to 24.1 times next year. That kind of rating requires rapid growth in sales and profits; in this respect there are some concerns.